BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
219 hedge funds and large institutions have $1.31B invested in BioTelemetry, Inc. in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 84 increasing their positions, 74 reducing their positions, and 51 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 74
13% less capital invested
Capital invested by funds: $1.5B → $1.31B (-$189M)
13% less funds holding
Funds holding: 251 → 219 (-32)
44% less call options, than puts
Call options by funds: $7.11M | Put options by funds: $12.6M
61% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 51
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$42.2M |
| 2 |
RA
Royce & Associates
New York
|
+$9.52M |
| 3 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$8.05M |
| 4 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
+$7.79M |
| 5 |
N
Natixis
Paris,
France
|
+$7.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$15.5M |
| 2 |
Bank of New York Mellon
New York
|
-$9.94M |
| 3 |
Morgan Stanley
New York
|
-$3.85M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$3.69M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$3.32M |
BEAT Hedge Fund Activity: Q3 2019 in Review
219 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q3 2019, worth a combined $1.31B — down 13% from $1.5B a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of BEAT and 20 opened new positions — a net loss of 31 holders — while 74 trimmed existing stakes and 84 added.
The largest buyer was ArrowMark Colorado Holdings, adding an estimated $42.2M. The largest seller was Hood River Capital Management, exiting entirely with an estimated $15.5M sold.
- 219 institutional investors held BioTelemetry, Inc. (BEAT) as of Q3 2019, down from 251 in Q2 2019.
- Funds reported $1.31B of BioTelemetry, Inc. stock for Q3 2019, down 13% quarter-over-quarter.
- 20 funds opened new BioTelemetry, Inc. positions in Q3 2019 and 51 closed out, a net change of -31 holders.
- The largest BioTelemetry, Inc. buyer in Q3 2019 was ArrowMark Colorado Holdings, an estimated $42.2M added.
- The largest BioTelemetry, Inc. seller in Q3 2019 was Hood River Capital Management, an estimated $15.5M sold.
Based on aggregated 13F filings for Q3 2019.